| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toll-Like Receptor 4 | 5 | 2013 | 114 | 1.230 |
Why?
|
| Interleukin-6 | 6 | 2012 | 330 | 1.000 |
Why?
|
| Lipopolysaccharides | 8 | 2016 | 455 | 0.840 |
Why?
|
| Acetaminophen | 1 | 2022 | 111 | 0.790 |
Why?
|
| Matrix Metalloproteinase 1 | 5 | 2013 | 74 | 0.750 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2022 | 131 | 0.750 |
Why?
|
| Adipocytes | 2 | 2011 | 88 | 0.720 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 124 | 0.710 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 4 | 2009 | 82 | 0.520 |
Why?
|
| Ethanol | 1 | 2022 | 892 | 0.520 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2018 | 133 | 0.520 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 63 | 0.520 |
Why?
|
| S-Nitrosoglutathione | 1 | 2016 | 87 | 0.510 |
Why?
|
| Glucose | 4 | 2013 | 307 | 0.480 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 132 | 0.470 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2013 | 10 | 0.450 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 232 | 0.450 |
Why?
|
| Sepsis | 1 | 2016 | 233 | 0.450 |
Why?
|
| Paracrine Communication | 1 | 2011 | 31 | 0.400 |
Why?
|
| Kidney | 1 | 2016 | 945 | 0.390 |
Why?
|
| NF-kappa B | 3 | 2012 | 432 | 0.390 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2009 | 134 | 0.390 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2009 | 435 | 0.350 |
Why?
|
| Osteopontin | 1 | 2009 | 28 | 0.350 |
Why?
|
| Animals | 20 | 2022 | 20880 | 0.340 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2009 | 15 | 0.340 |
Why?
|
| Putamen | 2 | 2009 | 35 | 0.330 |
Why?
|
| Macrophages | 2 | 2009 | 647 | 0.320 |
Why?
|
| Lactic Acid | 1 | 2009 | 86 | 0.320 |
Why?
|
| Rats | 12 | 2016 | 5300 | 0.320 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 81 | 0.300 |
Why?
|
| Nucleus Accumbens | 3 | 2009 | 417 | 0.300 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 4 | 2016 | 51 | 0.290 |
Why?
|
| Cocaine | 3 | 2009 | 555 | 0.280 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2015 | 175 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 290 | 0.270 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 370 | 0.260 |
Why?
|
| Mice | 9 | 2022 | 8474 | 0.260 |
Why?
|
| Cochlear Nerve | 3 | 2015 | 83 | 0.240 |
Why?
|
| Monocytes | 3 | 2013 | 210 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2016 | 2083 | 0.220 |
Why?
|
| Neuroglia | 2 | 2015 | 136 | 0.210 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2022 | 10 | 0.210 |
Why?
|
| Glycosides | 1 | 2022 | 14 | 0.210 |
Why?
|
| Endocytosis | 4 | 2016 | 113 | 0.210 |
Why?
|
| Acetaldehyde | 1 | 2022 | 18 | 0.210 |
Why?
|
| Cell Line | 7 | 2018 | 1752 | 0.210 |
Why?
|
| Disulfiram | 1 | 2022 | 22 | 0.210 |
Why?
|
| Coculture Techniques | 3 | 2011 | 147 | 0.200 |
Why?
|
| Phenols | 1 | 2022 | 73 | 0.200 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 84 | 0.200 |
Why?
|
| Necrosis | 1 | 2022 | 239 | 0.200 |
Why?
|
| Drug Combinations | 1 | 2022 | 304 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 89 | 0.200 |
Why?
|
| Protein Kinases | 1 | 2022 | 122 | 0.200 |
Why?
|
| Protein Kinase C | 4 | 2006 | 270 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.190 |
Why?
|
| Tacrolimus | 1 | 2022 | 127 | 0.190 |
Why?
|
| U937 Cells | 5 | 2013 | 61 | 0.180 |
Why?
|
| Autophagy | 1 | 2022 | 208 | 0.180 |
Why?
|
| Biological Variation, Population | 1 | 2019 | 8 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2019 | 93 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2019 | 30 | 0.160 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 90 | 0.160 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 85 | 0.160 |
Why?
|
| Protein Transport | 4 | 2008 | 280 | 0.160 |
Why?
|
| Gene Expression | 3 | 2018 | 770 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 562 | 0.160 |
Why?
|
| Hearing Loss, Central | 2 | 2015 | 9 | 0.160 |
Why?
|
| Cytokines | 3 | 2019 | 866 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2022 | 718 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 507 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 48 | 0.150 |
Why?
|
| Peroxisomes | 1 | 2018 | 48 | 0.150 |
Why?
|
| Membrane Microdomains | 3 | 2007 | 32 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 710 | 0.150 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 597 | 0.150 |
Why?
|
| Lovastatin | 1 | 2018 | 78 | 0.150 |
Why?
|
| Cricetulus | 2 | 2015 | 98 | 0.150 |
Why?
|
| Dopamine | 3 | 2009 | 474 | 0.150 |
Why?
|
| CHO Cells | 2 | 2015 | 161 | 0.150 |
Why?
|
| Phosphorylation | 8 | 2009 | 1200 | 0.150 |
Why?
|
| Serotonin | 5 | 2016 | 144 | 0.140 |
Why?
|
| Liver | 1 | 2022 | 1118 | 0.140 |
Why?
|
| Threonine | 2 | 2007 | 47 | 0.140 |
Why?
|
| Imidazoles | 2 | 2009 | 175 | 0.140 |
Why?
|
| Blood Urea Nitrogen | 1 | 2016 | 65 | 0.140 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2016 | 37 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2013 | 2689 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 1293 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 201 | 0.130 |
Why?
|
| Creatinine | 1 | 2016 | 243 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 53 | 0.130 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2015 | 24 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 2791 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2015 | 69 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2016 | 233 | 0.130 |
Why?
|
| Interleukin-10 | 1 | 2016 | 144 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 32 | 0.130 |
Why?
|
| Fibroblasts | 2 | 2012 | 902 | 0.130 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.130 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 184 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 126 | 0.130 |
Why?
|
| Up-Regulation | 4 | 2011 | 682 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2550 | 0.120 |
Why?
|
| Glutathione | 1 | 2016 | 343 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 234 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2016 | 382 | 0.120 |
Why?
|
| Glycerol Kinase | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2015 | 524 | 0.120 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2013 | 6 | 0.120 |
Why?
|
| Rhodobacter sphaeroides | 1 | 2013 | 6 | 0.120 |
Why?
|
| Stem Cells | 1 | 2015 | 248 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 626 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2010 | 282 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 331 | 0.110 |
Why?
|
| Heart Rate | 1 | 2015 | 568 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 247 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2673 | 0.110 |
Why?
|
| Mitochondria | 1 | 2018 | 643 | 0.110 |
Why?
|
| Humans | 18 | 2019 | 68549 | 0.110 |
Why?
|
| Cell Communication | 2 | 2009 | 116 | 0.100 |
Why?
|
| Myelin Basic Protein | 1 | 2012 | 62 | 0.100 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Simvastatin | 2 | 2010 | 34 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 16 | 0.100 |
Why?
|
| Cocaine-Related Disorders | 2 | 2009 | 504 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 34 | 0.100 |
Why?
|
| Caudate Nucleus | 2 | 2009 | 56 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2013 | 204 | 0.100 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 20 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 498 | 0.100 |
Why?
|
| Hearing | 1 | 2012 | 133 | 0.100 |
Why?
|
| Ear, Inner | 1 | 2011 | 47 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 1745 | 0.090 |
Why?
|
| Nerve Degeneration | 1 | 2011 | 134 | 0.090 |
Why?
|
| Phagocytes | 1 | 2010 | 15 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2010 | 71 | 0.090 |
Why?
|
| Female | 7 | 2019 | 38021 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 60 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 61 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 140 | 0.090 |
Why?
|
| Self Administration | 2 | 2009 | 419 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2008 | 791 | 0.090 |
Why?
|
| Flavonoids | 1 | 2009 | 109 | 0.080 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 2 | 2006 | 21 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2006 | 447 | 0.080 |
Why?
|
| Sweetening Agents | 1 | 2009 | 23 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 2 | 2009 | 67 | 0.080 |
Why?
|
| Antibodies | 1 | 2009 | 241 | 0.080 |
Why?
|
| RNA Interference | 1 | 2009 | 266 | 0.080 |
Why?
|
| Synaptosomes | 2 | 2007 | 57 | 0.080 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2007 | 12 | 0.080 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2007 | 9 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 742 | 0.080 |
Why?
|
| Second Messenger Systems | 1 | 2007 | 53 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 102 | 0.070 |
Why?
|
| Cyclic GMP | 1 | 2007 | 99 | 0.070 |
Why?
|
| Antioxidants | 1 | 2009 | 304 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.070 |
Why?
|
| Serine | 1 | 2006 | 99 | 0.070 |
Why?
|
| Aging | 1 | 2012 | 911 | 0.070 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2005 | 10 | 0.070 |
Why?
|
| Syntaxin 1 | 1 | 2005 | 6 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2005 | 71 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 244 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 138 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 67 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2004 | 30 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2005 | 220 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2004 | 37 | 0.060 |
Why?
|
| Symporters | 1 | 2004 | 27 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 1074 | 0.060 |
Why?
|
| Immunization | 1 | 2004 | 86 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2004 | 114 | 0.060 |
Why?
|
| Male | 9 | 2019 | 37283 | 0.060 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.050 |
Why?
|
| Neurons | 1 | 2007 | 881 | 0.050 |
Why?
|
| Mice, Inbred CBA | 2 | 2012 | 107 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 236 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 208 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 929 | 0.050 |
Why?
|
| Population Groups | 1 | 2019 | 16 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 98 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2013 | 241 | 0.040 |
Why?
|
| Ribonucleotides | 1 | 2018 | 26 | 0.040 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2018 | 25 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 32 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 37 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 182 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2019 | 285 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2018 | 244 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 314 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 13 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 317 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2015 | 42 | 0.030 |
Why?
|
| Hypoadrenocorticism, Familial | 1 | 2013 | 3 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2013 | 17 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 92 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1033 | 0.030 |
Why?
|
| Gingiva | 1 | 2012 | 34 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 196 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 434 | 0.030 |
Why?
|
| RNA Stability | 1 | 2011 | 55 | 0.020 |
Why?
|
| Ouabain | 1 | 2011 | 32 | 0.020 |
Why?
|
| Spiral Ganglion | 1 | 2011 | 47 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 250 | 0.020 |
Why?
|
| Curcumin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 14842 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 150 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 85 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 147 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 210 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 331 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 260 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 2009 | 240 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 659 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 21119 | 0.020 |
Why?
|
| Quinpirole | 1 | 2007 | 26 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2007 | 30 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 21379 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1663 | 0.020 |
Why?
|
| Exocytosis | 1 | 2007 | 34 | 0.020 |
Why?
|
| Diffusion | 1 | 2007 | 90 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 82 | 0.020 |
Why?
|
| Phosphoamino Acids | 1 | 2007 | 2 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2007 | 68 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2007 | 112 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2007 | 84 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 492 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 262 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 261 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 223 | 0.020 |
Why?
|
| Alanine | 1 | 2006 | 38 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 77 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 137 | 0.020 |
Why?
|
| Cholesterol | 1 | 2007 | 331 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 376 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 204 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 307 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2005 | 30 | 0.020 |
Why?
|
| Phorbols | 1 | 2005 | 8 | 0.020 |
Why?
|
| Membrane Transport Modulators | 1 | 2005 | 23 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2005 | 237 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2005 | 228 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2004 | 33 | 0.020 |
Why?
|
| Antigens | 1 | 2004 | 90 | 0.010 |
Why?
|
| Caveolins | 1 | 2004 | 6 | 0.010 |
Why?
|
| Trophoblasts | 1 | 2004 | 29 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1082 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 753 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1446 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2004 | 59 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 782 | 0.010 |
Why?
|
| GABA-B Receptor Antagonists | 1 | 2003 | 3 | 0.010 |
Why?
|
| GABA-B Receptor Agonists | 1 | 2003 | 5 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 35 | 0.010 |
Why?
|
| Receptors, GABA-B | 1 | 2003 | 10 | 0.010 |
Why?
|
| GABA Antagonists | 1 | 2003 | 22 | 0.010 |
Why?
|
| GABA Agonists | 1 | 2003 | 23 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2003 | 165 | 0.010 |
Why?
|
| Microdialysis | 1 | 2003 | 147 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2003 | 121 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 99 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 4843 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 567 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2003 | 332 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1329 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 2334 | 0.010 |
Why?
|